Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients
Open Access
- 5 September 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
- Vol. 8 (6) , 692-700
Abstract
Aims: To assess the prognosis of patients with coronary heart disease (CHD) after first myocardial revascularisation procedure in real-world practice and to compare the differences in outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) among diabetic and non-diabetic patients.Methods and results: A database was compiled from the national hospital discharge register to collect data on all cardiac revascularisations performed in Finland in 2000–2015. The outcomes (all-cause deaths, cardiovascular (CV) deaths, major CV events and need for repeat revascularisation) after the first revascularisation were identified from the national registers at 28 day, 1 year, and 3 year time points.A total of 139 242 first-time revascularisations (89 493 PCI and 49 749 CABG) were performed during the study period. Of all the revascularised patients, 24% had diabetes, and 76% were non-diabetic patients. At day 28, the risk of fatal outcomes was lower after PCI than after CABG among non-diabetic patients, whereas no difference was seen among diabetic patients. In long-term follow-up the situation was reversed with PCI showing higher risk compared with CABG for most of the outcomes. In particular, at 3 year follow-up the risk of all-cause deaths was elevated among diabetic patients [HR 1.30 (95% CI 1.22–1.38) comparing PCI with CABG] more than among non-diabetic patients [HR 1.09 (1.04–1.15)]. The same was true for CV deaths [HR 1.29 (1.20–1.38) among diabetic patients, and HR 1.03 (0.98–1.08) among non-diabetic patients].Conclusion: Although PCI was associated with better 28 day prognosis, CABG seemed to produce better long-term prognosis especially among diabetic patients.Keywords
Funding Information
- Finnish Foundation for Cardiovascular Research
- Research Council of Finland (321351)
- Emil Aaltonen Foundation
This publication has 26 references indexed in Scilit:
- Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial†European Journal of Cardio-Thoracic Surgery, 2013
- Use of Medications for Secondary Prevention After Coronary Bypass Surgery Compared With Percutaneous Coronary InterventionJACC, 2013
- Strategies for Multivessel Revascularization in Patients with DiabetesNew England Journal of Medicine, 2012
- Quality of the Finnish Hospital Discharge Register: A systematic reviewScandinavian Journal of Public Health, 2012
- Comparative Effectiveness of Revascularization StrategiesNew England Journal of Medicine, 2012
- A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Diabetes and Mortality Following Acute Coronary SyndromesJAMA, 2007
- The Final 10-Year Follow-Up Results From the BARI Randomized TrialJACC, 2007
- Mortality and causes of death in the WHO multinational study of vascular disease in diabetesDiabetologia, 2001
- Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcomeDiabetologia, 2000